Intestinal Microbiota in New-born Infants Impacts Vaccine Response

25 Jul 2019
newborn
25 Jul 2019

newborn
Dr Heather Jaspan of the Division of Immunology recently co-authored a paper entitled “Impact of Gut Microbiota on Vaccine Response in HIV Exposed Infants” published online in July 2019 in The Journal of Immunology.

Infants of HIV infected mothers have been shown to have altered composition and diversity of gut microbiota. The researchers investigated whether HIV-exposed uninfected (HEU) infants who have inherited altered microbiota also have a poor response to vaccines.

The study was completed by using a germ-free mouse model where the relationship between stool microbiota in HEU infants and the BCG vaccine was investigated. BCG vaccine Th1 responses were assessed and later BCG specific T cells were quantified.

Mouse pups that were gavaged with high responder stool (Phr) samples had a significantly lower spleen cell count and a significantly higher proportion of effector memory CD4 T cells (CD4+CD44hiCD62Llo) relative to low responder stool (Plr). And the” total number of B cells and neutrophils were significantly reduced in Phr vs Plr”. When the mice were vaccinated with BCG; “Phr displayed significantly higher number of TB10.4-specific CD8 T cells compared to Plr.”

Dr Heather Jaspan and her cohorts showed that there is a direct role of the microbiota in inherent immunity in infants. The microbiota in low responder HEU infants caused a reduced number of specific CD8 T cells. This study shows for the first time that the gut microbiota in human infants at birth impacts the child’s vaccine response.

Read the paper - Impact of Gut Microbiota on Vaccine Response in HIV Exposed Infants

Article by Bonamy Holtak